High Outlier
Strength
375 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332001850
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
1/21/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA079065On Market Since
12/9/2016
Pharmacological Classes
Nitroimidazole Antimicrobial
Nitroimidazoles
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
METRONIDAZOLE 250 MG TABLET
Generic
00904715661•Major Pharmaceuticals
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
16571066501•Rising Pharma Holdings Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
16571066550•Rising Pharma Holdings Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
23155065101•Heritage Pharmaceuticals Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
23155065105•Heritage Pharmaceuticals Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
29300022601•Unichem Pharmaceuticals (USA) Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
29300022605•Unichem Pharmaceuticals (USA) Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
29300022652•Unichem Pharmaceuticals (USA) Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
50111033301•Teva Pharmaceuticals USA Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
50111033302•Teva Pharmaceuticals USA Inc.
$0.0791
per EA